HistoIndex Announces Global Partnerships To Expand AI-Based Digital Pathology Platform As A Drug Discovery Tool In Preclinical Studies For Nonalcoholic Steatohepatitis (NASH)
- Saturday, October 26, 2019, 7:17
- PR Newswire
- Add a comment
SINGAPORE, Oct. 26, 2019 /PRNewswire/ — HistoIndex announces the expansion of its AI-based digital pathology platform towards large-scale NASH preclinical programs for pharmaceutical and biotech companies to achieve quantifiable and reproducible data on therapeutic responses in NASH…
About the Author
admin has written 20655 stories on this site.